All posts tagged "Covaxin"
-
Analysis
Majority of Indians experience no or mild side effects post 2 doses of Covid vax: Survey
August 25, 2021Majority of Indians experienced no or only mild side effects after taking two doses of COVID-19...
-
COVID19
Zydus-Cadila 3-dose COVID-19 vaccine gets EUA for children above 12 years
August 21, 2021Zydus-Cadila three-dose COVID-19 vaccine has been given the green light for emergency use authorization for use...
-
COVID19
India has done better than any country across world in vaccination: Bharat Biotech CMD
August 15, 2021India has done better than any country in the world as regards to affordability and the...
-
COVID19
Mixing Covishield and Covaxin yields better results: ICMR Study
August 8, 2021Combining Covishield and Covaxin elicited better immunogenicity than two doses of the same vaccine, reveals a...
-
Analysis
India very much vulnerable to a third COVID-19 wave amid shortage of vaccines
July 20, 2021Millions of Indians across the country remain vulnerable to the impending third wave of COVID-19 wave...
-
COVID19
Bharat Biotech’s partner Ocugen seeks clearance for Covaxin in Canada
July 16, 2021Ocugen Inc., Bharat Biotech’s partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a...
-
COVID19
Covaxin to get WHO’s emergency use approval at earliest: Bharat Biotech
July 13, 2021Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing...
-
COVID19
Brazil suspends $324 million Covaxin contract due to irregularities
June 30, 2021Brazil is set to suspend a $324 million Covaxin contract, a deal to buy 20 million...
-
COVID19
India could get its anti-covid vaccine for children in September: AIIMS director
June 23, 2021AIIMS, director Dr Randeep Guleria has said that Bharat Biotech’s anti-covid vaccine, Covaxin, is expected to...
-
COVID19
Covaxin: Bharat Biotech submits phase 3 trial data; DCGI expert panel meet today
June 22, 2021Hyderabad-based vaccine maker Bharat Biotech has submitted data from Phase III trials of its Covaxin coronavirus...
